131 related articles for article (PubMed ID: 11422216)
1. Ouabain-induced coronary vasoconstriction in cats is not neurally mediated.
Nair BA; Murad YZ; Brody MJ; Gutterman DD
Clin Exp Pharmacol Physiol; 2001 Jul; 28(7):510-7. PubMed ID: 11422216
[TBL] [Abstract][Full Text] [Related]
2. Ouabain induced primary coronary vasoconstriction. 1.
Bloor CM; Walker DE; Pensinger RR
Proc Soc Exp Biol Med; 1972 Sep; 140(4):1409-13. PubMed ID: 5057605
[No Abstract] [Full Text] [Related]
3. Inhibition of nitric oxide synthesis augments centrally induced sympathetic coronary vasoconstriction in cats.
Goodson AR; Leibold JM; Gutterman DD
Am J Physiol; 1994 Oct; 267(4 Pt 2):H1272-8. PubMed ID: 7943371
[TBL] [Abstract][Full Text] [Related]
4. The importance of a central adrenergic mechanism in the cardiovascular responses to ouabain.
Saxena PR; Bhargava KP
Eur J Pharmacol; 1975 Apr; 31(2):332-46. PubMed ID: 1056858
[TBL] [Abstract][Full Text] [Related]
5. Effect of stellate ganglionectomy on basal cardiovascular function and responses to beta1-adrenoceptor blockade in the rat.
Yoshimoto M; Wehrwein EA; Novotny M; Swain GM; Kreulen DL; Osborn JW
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2447-54. PubMed ID: 18931026
[TBL] [Abstract][Full Text] [Related]
6. Activation in the region of parabrachial nucleus elicits neurogenically mediated coronary vasoconstriction.
Miller FJ; Marcus ML; Brody MJ; Gutterman DD
Am J Physiol; 1991 Nov; 261(5 Pt 2):H1585-96. PubMed ID: 1683174
[TBL] [Abstract][Full Text] [Related]
7. Compared peripheral vascular responses to intravenous and intra-arterial administrations of positive inotropic agents in conscious dogs.
Gosgnach M; Gérard JL; Berdeaux A; Giudicelli JF
Fundam Clin Pharmacol; 1991; 5(8):709-18. PubMed ID: 1783360
[TBL] [Abstract][Full Text] [Related]
8. Intravenous phentolamine abolishes coronary vasoconstriction in response to mild central hypovolemia.
Gao Z; Muller MD; Sinoway LI; Leuenberger UA
J Appl Physiol (1985); 2014 Jan; 116(2):216-21. PubMed ID: 24311747
[TBL] [Abstract][Full Text] [Related]
9. Characterization of coronary vasoconstrictor site in medullary reticular formation.
Gutterman DD; Bonham AC; Arthur JM; Gebhart GF; Marcus ML; Brody MJ
Am J Physiol; 1989 Apr; 256(4 Pt 2):H1218-27. PubMed ID: 2565092
[TBL] [Abstract][Full Text] [Related]
10. Neurogenic regulation of coronary blood flow: evidence for a central nervous system pathway.
Bonham AC; Gutterman DD; Arthur JM; Marcus ML; Gebhart GF; Brody MJ
Circ Res; 1987 Nov; 61(5 Pt 2):II42-6. PubMed ID: 2444359
[TBL] [Abstract][Full Text] [Related]
11. Role of parabrachial nucleus in baroreflex-mediated coronary vasoconstriction.
Gutterman DD; Goodson A
Am J Physiol; 1996 Sep; 271(3 Pt 2):H1079-86. PubMed ID: 8853344
[TBL] [Abstract][Full Text] [Related]
12. Effect of ouabain on large coronary artery diameter.
Schwartz JS; Bache RJ
J Cardiovasc Pharmacol; 1988 May; 11(5):608-13. PubMed ID: 2455848
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1995 Jun; 115(4):579-86. PubMed ID: 7582475
[TBL] [Abstract][Full Text] [Related]
14. Opposing responses in sympathetic nerve activity induced by central injections of ouabain.
Weaver LC; Akera T; Brody TM
J Pharmacol Exp Ther; 1975 Oct; 195(1):114-25. PubMed ID: 1102662
[TBL] [Abstract][Full Text] [Related]
15. Heart rate variability in conscious neonatal swine: spectral features and responses to short-term intermittent hypoxia.
Sica AL; Zhao N
BMC Physiol; 2006 Jun; 6():5. PubMed ID: 16780581
[TBL] [Abstract][Full Text] [Related]
16. Coronary arteriolar vasoconstriction in myocardial ischaemia: reflexes, sympathetic nervous system, catecholamines.
Longhurst JC
Eur Heart J; 1990 Apr; 11 Suppl B():43-52. PubMed ID: 2364955
[TBL] [Abstract][Full Text] [Related]
17. Nonuniform cardiac sympathetic nerve discharge: mechanism for coronary occlusion and digitalis-induced arrhythmia.
Lathers CM; Kelliher GJ; Roberts J; Beasley AB
Circulation; 1978 Jun; 57(6):1058-65. PubMed ID: 639225
[TBL] [Abstract][Full Text] [Related]
18. Interaction of ouabain and propranolol in the central nervous system. Neurally-mediated effects on the cardiovascular system.
Sivam SP; Seth SD; Nayar U; Manchanda SC
Pharmacology; 1982; 25(5):286-93. PubMed ID: 7178228
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and myocardial energetic effects of CK-3197, a selective positive inotropic agent.
Greenberg S; Touhey B
J Cardiovasc Pharmacol; 1991 Jan; 17(1):145-53. PubMed ID: 1708048
[TBL] [Abstract][Full Text] [Related]
20. Effects of ouabain on in situ cardiac sympathetic nerve endings.
Yamazaki T; Akiyama T; Kawada T
Neurochem Int; 1999 Dec; 35(6):439-45. PubMed ID: 10524711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
